Clinical Trial Update: Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing telbivudine with adefovir dipivoxil in adults with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED